Serological biomarkers as risk factors of SLE-associated pulmonary arterial hypertension: a systematic review and meta-analysis
Authors:
- 14 April 2017
- journal article
- review article
- Published by SAGE Publications in Lupus
- Vol. 26 (13) , 1390-1400
Abstract
Objective: This article aims to determine the serological biomarkers which can be considered as risk factors of systemic lupus erythematosus (SLE)-associated pulmonary arterial hypertension by a systematic review and meta-analysis. Methods: This study was conducted in accordance with the PRISMA statement. The search database included MEDLINE, EMBASE, Cochrane Library and Scopus. The Newcastle–Ottawa scale was used for the quality assessment. The odds ratio was the primary measure of effect of the risk factors. Results: Twelve studies were included in this meta-analysis. The results identified the anti-RNP antibody and anti-Sm antibody as risk factors for SLE-associated pulmonary arterial hypertension with the pooled odds ratios 3.68 (95% confidence interval 2.04–6.63, P < 0.0001) and 1.71 (95% confidence interval 1.06–2.76, P = 0.03), respectively. Conclusion: Pulmonary arterial hypertension is a serious complication of SLE with a worse prognosis than SLE patients without pulmonary arterial hypertension. The early recognition of pulmonary arterial hypertension with transthoracic echocardiography routinely performed in SLE patients with risk factors is necessary, especially in Asian patients.Keywords
Funding Information
- Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02)
- Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513)
This publication has 41 references indexed in Scilit:
- Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategyAutoimmunity Reviews, 2013
- Asymptomatic Pulmonary Hypertension in Systemic Lupus ErythematosusClinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 2011
- Clinical and Serologic Correlations and Autoantibody Clusters in Systemic Lupus ErythematosusMedicine, 2010
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- Prevalence and risk factors for pulmonary arterial hypertension in patients with lupusRheumatology, 2009
- Interleukin-6 Overexpression Induces Pulmonary HypertensionCirculation Research, 2009
- Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in miceRespiratory Research, 2009
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosusAmerican Heart Journal, 1995
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982